[1]Wang JY, Wang XL, Liu P.Detection of serum TNF-α, IFN-γ, IL-6 and IL-8 in patients with hepatitis B[J].World GastroenterolJ, 1999, 5 (1) ∶38-40.
|
[2]余红岚, 刘若英, 宋静芳, 等.病毒性乙型肝炎患者Th细胞亚群与ALT、IgG、C3的相关性研究[J].贵阳医学院学报, 2004, 29 (2) ∶118-121.
|
[3]龚非力.医学免疫学[M].第二版.北京:科学出版社, 2004∶42-59.
|
[4]高美华, 许化溪.医学免疫学[M].北京:人民军医出版社, 1999∶62.
|
[5]邹焕荣, 张旭, 何国坚, 等.乙型肝炎患者血清补体C3含量的分析[J].国际医药卫生导报, 2004, 10 (2-3) (下半月刊) ∶61-62.
|
[6]毛远丽, 王海滨, 孙志强, 等.慢性肝炎患者ECR1基因多态性、数量及活性的变化[J].中华实验和临床病毒学杂志, 2003, 17 (2) ∶146-148.
|
[7]韦丽霞, 唐任光, 杨柳, 等.免疫球蛋白及补体检测在肝炎诊断中的意义[J].右江民族医学院学报, 2006, 28 (2) ∶266-267.
|
[8] 李伟, 陈益平, 汪洪娇.血清补体C3、C4水平与儿童慢性乙肝的临床关系[J].温州医学院学报, 2002, 32 (5) ∶317-318.
|
[9]张占卿, 董华娟, 王冯滨, 等.亚急性重型肝炎早期外周血免疫学指标改变的特点及其意义[J].世界感染杂志, 2004, 4 (4) ∶350-353.
|
[10] 迟丽娜, 黄俊佩.重型肝炎患者IgA、IgG、IgM、C3检测的临床意义[J].中西医结合肝病杂志, 2002, 12 (4) ∶220.
|
[1] | Chen Hao, Hao JianHeng, Li ZhenCheng, Xu HuiChao, Gao Yan, Miao YuChuan, Hao HuiQin, Liu Yang. Screening for differentially expressed genes in mice with autoimmune hepatitis and effect of saikosaponin-d on the expression of several differentially expressed genes[J]. Journal of Clinical Hepatology, 2020, 36(4): 840-846. doi: 10.3969/j.issn.1001-5256.2020.04.026 |
[2] | Shi HaiYan, Li LiYa, He HaoLan, Liu HuiYuan, Chen ZhiMin, Chen WeiLie, Liao BaoLin. Association of HBV precore/core promoter variants with the degree of liver fibrosis in patients with HBeAg-positive chronic hepatitis B[J]. Journal of Clinical Hepatology, 2018, 34(5): 1020-1024. doi: 10.3969/j.issn.1001-5256.2018.05.019 |
[3] | Zhou LianLian, Shen Mo, Zhou Ping, Zhou Wu, Lin XiangYang. HBV genotype distribution and its relationship with serum HBV DNA level and HBeAg expression among patients with chronic hepatitis B in southern Zhejiang Province, China[J]. Journal of Clinical Hepatology, 2014, 30(10): 1039-1041. doi: 10.3969/j.issn.1001-5256.2014.10.016 |
[4] | Deng Le, Wen ZhiLi. Review of recent research progress in correlating HBV genotypes with efficacy of antiviral treatments[J]. Journal of Clinical Hepatology, 2012, 28(6): 469-473. |
[5] | Yang YanLin, Xiao Ping, Gao Peng, Wang LiMing, Wei XiSheng, He Qiang, Zhou Ping. Distribution of HBV genotypes and YMDD mutations in E antigen-positive patients[J]. Journal of Clinical Hepatology, 2012, 28(6): 428-430. |
[6] | Guo XinHui, Yan Yan, Li Zhuo, Yin JiMing. Fluorescent reverse transcription-PCR assay for determination of hepatitis C virus genotypes[J]. Journal of Clinical Hepatology, 2011, 27(1): 65-67. |
[7] | Cheng Ling, Hong GuoHu, Guo Yan, Mao Qing. Prediction of HLA-DRB1*0311/0401 in recognizing epitopes of HCV Core protein of different genotypes[J]. Journal of Clinical Hepatology, 2011, 27(1): 61-64. |
[8] | Liu JinPing, Liu YouDe, Guo YanMei, Yang ShaoPing, Lin Qing, Lin Ling. Clinical characteristics and distribution of hepatitis B virus genotypes in CHB patients in Yantai area[J]. Journal of Clinical Hepatology, 2011, 27(12): 1288-1290. |
[9] | Zhang WenJie, Liu LiJun, Du ShaoCai, Li ChaoXia, Lu QingYun, Yang ShaoHua. The prevalence of hepatitis C virus genotype in Lanzhou area[J]. Journal of Clinical Hepatology, 2010, 26(3): 290-291+294. |
[10] | Wang GuoQiang, Niu JuXia. The HBx protein mutation among different HBV genotypes[J]. Journal of Clinical Hepatology, 2010, 26(4): 392-394. |
[12] | Li Jun, Chen XinYue, Zhao Hong, Yu YanYan, Si ChongWen, Han ZhongHou, Zhang WenJin, Chen YuPing, Chen Yong, Wang GuiQiang, Yu Min, Gong WeiBo, Xu JingHang, Wang Jun, Lin XiaoHong, Li XueYing. The relationship of hepatitis B virus genotypes and efficacy of lamivudine and interferon alpha 2b in the treatment of HBeAg-positive chronic hepatitis B[J]. Journal of Clinical Hepatology, 2008, 24(3): 169-171. |
[13] | Xiao Yang, Hu CaoHan, Zhou YueJin, Xie QingRong, Zhu BingXing, Hu Xia, Wang KaiJian, Zhang WenJing. Effect of hepatitis B virus genotypes on response to interferon α2b in the treatment of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2006, 22(2): 105-106. |
[15] | Liu ChengYong, Hou YuanPei, Qian XiuMei, Sun Qing, Song Li. Distribution of hepatitis B virus genotype in Xuzhou and its clinical significance[J]. Journal of Clinical Hepatology, 2005, 21(3): 151-152. |
[16] | Li TingMing, Zhu YouFu, He HaiTang, Mao QianGuo, Wu AiHua, Liang YuFang, Luo KangXian. The relation between chinese hepatitis B virus genotype B C and efficacy of interferon-α.[J]. Journal of Clinical Hepatology, 2005, 21(1): 16-18. |
[17] | Xu ZhengJu, Yang Hong, Zhang QiHua, Chen XianLi, Li ShuQing, Wang ChongGuo. Study on the relationship between hepatitis B virus genotypes and effect of lamivudine therapy.[J]. Journal of Clinical Hepatology, 2005, 21(3): 157-159. |
[18] | Jiao Jian, Wang JiangBin. Distribution of HCV genotypes and its clinical features in patients coinfected with HCV and HBV[J]. Journal of Clinical Hepatology, 2004, 20(2): 75-76. |
[19] | Lu YinYing, Wang Lin, Liu Yan, Li Ke, Cheng Jun, Zhang LingXia, Li Li. Cloning and expression of gene of hepatitis B virus e antigen in yeast[J]. Journal of Clinical Hepatology, 2003, 19(3): 166-168. |
[20] | Yao Gang, Zhang Lian, Bao LiHua. HBV genotypes and efficacy of interferon-α on patients with chronic hepatitis B.[J]. Journal of Clinical Hepatology, 2002, 18(5): 273-274. |